Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide and CPAP in Obstructive Sleep Apnea
NCT04186494Completed
- Sponsor
- St. Vincent's University Hospital
- Start
- Dec 2019
- Primary completion
- Dec 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, single-blind trial of liraglutide in obesity (3 arms), sponsored by St. Vincent's University Hospital. Primary endpoint: Insulin resistance at 6 months. Started Dec 2019; status: completed.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04186494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04186494.